Jiangsu Aidea Pharmaceutical Group Co., Ltd. (SHA:688488)
China · Delayed Price · Currency is CNY 16.70
+0.11 (0.66%)
Sep 23, 2026, 3:00 PM CST
SHA:688488 Revenue
Jiangsu Aidea Pharmaceutical Group had revenue of 187.83M CNY in the quarter ending June 30, 2026, with 14.10% growth. This brings the company's revenue in the last twelve months to 722.54M, up 20.58% year-over-year. In the year 2025, Jiangsu Aidea Pharmaceutical Group had annual revenue of 719.17M with 72.13% growth.
Revenue (ttm)
722.54M
Revenue Growth
+20.58%
P/S Ratio
9.73
Revenue / Employee
950.71K
Employees
760
Market Cap
7.03B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 719.17M | 301.37M | 72.13% |
| Dec 31, 2024 | 417.80M | 6.44M | 1.57% |
| Dec 31, 2023 | 411.36M | 167.14M | 68.44% |
| Dec 31, 2022 | 244.22M | -11.49M | -4.49% |
| Dec 31, 2021 | 255.71M | -33.35M | -11.54% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Star Lake Bioscience Co., Inc.Zhaoqing Guangdong | 15.93B |
| Youcare Pharmaceutical Group | 2.46B |
| Novogene | 2.28B |
| China Resources Boya Bio-pharmaceutical Group Co.,Ltd | 1.69B |
| Chengdu Kanghua Biological Products | 1.22B |
| R&G PharmaStudies | 939.31M |
| Zhejiang Ausun Pharmaceutical | 778.50M |
| Daan Gene | 746.91M |